1857 Final results of a phase II study evaluating oral vinorelbine as a single-agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial)

Cancer Patients ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Oral Vinorelbine ◽

Phase Ii Study Evaluating Oral Vinorelbine As a Single-Agent As First-Line Chemotherapy for Metastatic Breast Cancer Patients with Bone Metastases (Norbreast-228 Trial): First Efficacy Results

Annals of Oncology ◽

10.1093/annonc/mdu329.52 ◽

2014 ◽

Vol 25 ◽

pp. iv132

Author(s):

G.G. Steger ◽

A. Dominguez ◽

O. Switsers ◽

N. Dobrovolskaya ◽

F. Giotta ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Oral Vinorelbine ◽

First safety results of an international phase II study evaluating oral vinorelbine as a single agent as first-line chemotherapy for metastatic breast cancer patients with bone metastases (NorBreast-228 trial).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1048 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1048-1048

Author(s):

Guenther G. Steger ◽

Natalya Dobrovolskaya ◽

Adriana Dominguez ◽

Odile Switsers ◽

Francesco Giotta ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Oral Vinorelbine ◽

Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-009-1081-y ◽

2009 ◽

Vol 65 (4) ◽

pp. 755-763 ◽

Cited By ~ 18

Author(s):

Alison Jones ◽

Mary O’Brien ◽

Harald Sommer ◽

Elzbieta Nowara ◽

Anja Welt ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Phase Ii Study ◽

Metastatic Breast ◽

Second Line ◽

Breast Cancer Patients ◽

Oral Vinorelbine ◽

Previously Treated ◽

Single agent epirubicin as first line chemotherapy for metastatic breast cancer patients

Breast Cancer Research and Treatment ◽

10.1023/a:1006394801389 ◽

2000 ◽

Vol 59 (2) ◽

pp. 133-139 ◽

Cited By ~ 21

Author(s):

Andrea Michelotti ◽

Marco Venturini ◽

Carmelo Tibaldi ◽

Carmelo Bengala ◽

Luigi Gallo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)70892-3 ◽

2007 ◽

Vol 5 (4) ◽

pp. 223

Author(s):

N. Tubiana-Mathieu ◽

P. Bougnoux ◽

D. Becquart ◽

A. Chan ◽

F. Majois ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Oral Vinorelbine ◽

Carboplatin and docetaxel as first-line chemotherapy in metastatic breast cancer patients. Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.862 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 862-862

Author(s):

M. E. Vassilomanolakis ◽

G. Koumakis ◽

V. Barbounis ◽

S. Demiris ◽

C. Panopoulos ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Preliminary Results ◽

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdr263 ◽

2012 ◽

Vol 23 (3) ◽

pp. 618-624 ◽

Cited By ~ 180

Author(s):

J.-Y. Pierga ◽

D. Hajage ◽

T. Bachelot ◽

S. Delaloge ◽

E. Brain ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Predictive Value ◽

Prospective Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial

Annals of Oncology ◽

10.1093/annonc/mdf306 ◽

2002 ◽

Vol 13 (11) ◽

pp. 1717-1729 ◽

Cited By ~ 44

Author(s):

E. Heidemann ◽

H. Stoeger ◽

R. Souchon ◽

W.-D. Hirschmann ◽

H. Bodenstein ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Patients ◽

Combination Chemotherapy ◽

Single Agent ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line

First‐Line Chemotherapy for HER‐2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment

The Oncologist ◽

10.1634/theoncologist.12-11-1288 ◽

2007 ◽

Vol 12 (11) ◽

pp. 1288-1298 ◽

Cited By ~ 10

Author(s):

Alessandro Morabito ◽

Maria Carmela Piccirillo ◽

Katia Monaco ◽

Carmen Pacilio ◽

Francesco Nuzzo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her 2 ◽

Phase II Study of Single Agent Oral Vinorelbine (OV) as First-Line Chemotherapy (CT) in Patients (PTS) with HER-2 Negative Metastatic Breast Cancer (MBC): A Single Center Experience

Annals of Oncology ◽

10.1016/s0923-7534(20)32958-6 ◽

2012 ◽

Vol 23 ◽

pp. ix138

Author(s):

M. Mansour ◽

C. Mourad

Keyword(s):

Breast Cancer ◽

Phase Ii Study ◽

Single Agent ◽

Metastatic Breast ◽

Single Center ◽

First Line ◽

Oral Vinorelbine ◽

Single Center Experience ◽

Her 2 ◽